PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

SRI relaunches the PARC Forum event series as it celebrates the first anniversary of acquiring the storied Palo Alto Research Center

2024-03-04
(Press-News.org) Menlo Park, CA: SRI announced today the relaunch of PARC Forum, an event and program series that brings together some of the world’s leading thinkers for thought-provoking conversations at the intersection of technology and society. 

The first PARC Forum event marks the first anniversary of SRI’s acquisition through a donation from Xerox of the Palo Alto Research Center (PARC ). The acquisition brought together two iconic Silicon Valley organizations that have created and delivered technologies, services, and ideas that have had a profound impact on every one of our lives.    

SRI’s first PARC Forum event will be held on Thursday, April 4, when SRI’s Chief Executive Officer David Parekh sits down with Pulitzer Prize-winning New York Times editor and writer David Leonhardt to discuss his new book, Ours Was the Shining Future: The Story of the American Dream, and how innovation, ingenuity, and investment fueled America’s technological and economic growth. 

“To celebrate our first anniversary, SRI is proud to offer a renewed PARC Forum, a nearly 50-year-old Silicon Valley institution,” said David Parekh, SRI’s chief executive officer. “The event brings together global leaders in technology, science, and business with entrepreneurs and community members for networking and discussion about cutting-edge research, emerging trends in innovation, and technology’s transformative effects on the world.”

PARC Forum: A conversation between David Parekh and David Leonhardt
When:  April 4 at 5:00 p.m. PT; networking reception to follow at 6:00 p.m.
Where: SRI’s historic PARC Campus
How: PARC Forum events are free to those who register – secure your spot today!

David Leonhardt is a senior writer for The New York Times, where he writes The Morning, its flagship daily newsletter. He is the author of Ours Was the Shining Future: The Story of the American Dream (Random House, 2023). The Atlantic, the Financial Times and the New Republic named it one of the best books of the year. Previously at The Times, David was an Op-Ed columnist, the Washington bureau chief, a Times Magazine staff writer, a podcast host, and the founding editor of The Upshot section. He also led a strategy group that helped Times leadership shape the newsroom’s digital future. In 2011, David received the Pulitzer Prize for commentary.

David Parekh, Ph.D., is the chief executive officer of SRI, a leading research and development organization serving government and industry. Parekh has more than 30 years of experience leading research for industrial and academic research organizations. Parekh serves on the Board of Trustees of the Connecticut Science Center and served as a board director of the American Council for an Energy-Efficient Economy. He is a Fellow of the American Institute of Aeronautics and Astronautics and a member of the Connecticut Academy of Science and Engineering. He joined SRI in December of 2021.

About SRI
SRI is an independent nonprofit research institute headquartered in Menlo Park, California, with a rich history of supporting government and industry. We create and deliver world-changing solutions for a safer, healthier, and more sustainable future. For more than 75 years, we have collaborated across technical and scientific disciplines to discover and develop groundbreaking products and technologies and bring innovations and ideas to the marketplace. Learn more at www.sri.com.
 

END


ELSE PRESS RELEASES FROM THIS DATE:

An inside look at Beech tree disease

An inside look at Beech tree disease
2024-03-04
Beech trees provide food for animals, timber for wood products, and sustenance for beech drop plants, but they are under threat from Beech Leaf Disease (BLD). The disease, first documented in 2012 in the Midwest, is associated with the nematode Litylenchus crenatae mccannii and is spreading rapidly throughout the central and northeast regions of North America. A team of scientists led by Craig Brodersen, professor of plant physiological ecology, and Leila Fletcher, postdoctoral associate, at the Yale School of the Environment has uncovered ...

New AI model draws treasure maps to diagnose disease

New AI model draws treasure maps to diagnose disease
2024-03-04
Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors and diseases in medical images and is programmed to explain each diagnosis with a visual map. The tool’s unique transparency allows doctors to easily follow its line of reasoning, double-check for accuracy, and explain the results to patients. "The idea is to help catch cancer and disease in its earliest stages — like an X on ...

Breastfeeding after COVID-19 booster can give babies antibodies

2024-03-04
Lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine, a study from the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) and the UF College of Medicine found. The study is the third in a series that looks at antibody protection being transferred via breast milk from mothers who received their first two COVID-19 vaccinations and, now, the booster shot. The second publication reported the same antibody transfer via breast milk. “We think that breast milk may play an important ...

Researchers closing in on genetic treatments for hereditary lung disease, vision loss

Researchers closing in on genetic treatments for hereditary lung disease, vision loss
2024-03-04
PORTLAND, Ore. – Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss. Findings of the study led by Gaurav Sahay and Yulia Eygeris of the Oregon State University College of Pharmacy and Renee Ryals of Oregon Health & Science University were published today in the Proceedings of the National Academy of Sciences. Unlike other types of lipid nanoparticles that tend to accumulate in the liver, the ones in this study, ...

COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection

2024-03-04
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.    ----------------------------    1. COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection Vaccination showed some protection against AIRDs, depending on severity ...

UC Irvine receives $15 million NSF grant for integrative movement research

2024-03-04
Irvine, Calif. March 4, 2024 — The National Science Foundation has granted $15 million to the Integrative Movement Sciences Institute at the University of California, Irvine. This six-year funding, part of the NSF’s Biology Integration Institutes program, will support groundbreaking research led by Monica Daley, professor of ecology & evolutionary biology at the UCI School of Biological Sciences. The research funded by this grant aims to understand the intricate mechanics of muscle control during rapid, unsteady movements in complex environments. Muscle ...

University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements

University of Houston engineer Metin Akay featured in study highlighting 50 scientists contributions to biomedical engineering advancements
2024-03-04
Metin Akay, founding chair of the Biomedical Engineering Department at the University of Houston and John S. Dunn Professor, is one of 50 top scientists from 34 elite universities to publish a roadmap for groundbreaking research to transform the landscape of medicine in the coming decade.  Published on behalf of the Institute of Electrical and Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for humanity and the IEEE Engineering in Medicine and Biology Society (IEEE EMBS), the paper focus ...

JWST captures the end of planet formation

JWST captures the end of planet formation
2024-03-04
March 4, 2024, Mountain View, CA – The James Webb Space Telescope (JWST) is helping scientists uncover how planets form by advancing understanding of their birthplaces and the circumstellar disks surrounding young stars, in a paper published in the Astronomical Journal, a team of scientists led by Naman Bajaj of the University of Arizona and including Dr. Uma Gorti at the SETI Institute, image for the first time, winds from an old planet-forming disk (still very young relative to the Sun) which is actively dispersing its gas ...

Good news—MS drugs taken while breastfeeding may not affect child development

2024-03-04
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, MONDAY, MARCH 4, 2024 MINNEAPOLIS – Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab and ofatumumab. MS is a disease in which the body’s immune system attacks ...

Programs intended to reduce health insurance premiums may make coverage less affordable for the middle class

2024-03-04
PITTSBURGH, March 4, 2024 — Reinsurance programs, which were created to help lower premiums and increase enrollment in the Affordable Care Act’s health insurance marketplaces, may have had the opposite effects for many potential marketplace enrollees, according to a study by health policy researchers at the University of Pittsburgh School of Public Health, Duke University and University of Minnesota. The study, published today in Health Affairs, is the first to examine the effects of a post-American Rescue Plan Act ...

LAST 30 PRESS RELEASES:

UC San Diego Health ends negotiations with Tri-City Medical Center Healthcare District

MLB add lifesavers to the chain of survival in New York City

ISU studies explore win-win potential of grass-powered energy production

Study identifies biomarker that could predict whether colon cancer patients benefit from chemotherapy

Children are less likely to have type 1 diabetes if their mother has the condition than if their father is affected

Two shark species documented in Puget Sound for first time by Oregon State researchers

AI method radically speeds predictions of materials’ thermal properties

Study: When allocating scarce resources with AI, randomization can improve fairness

Wencai Liu earns 2024 IUPAP Early Career Scientist Prize in Mathematical Physics

Outsourcing conservation in Africa

Study finds big disparities in stroke services across the US

Media Tip Sheet: Urban Ecology at #ESA2024

Michigan Plasma prize honors University of Illinois professor

Atomic 'GPS' elucidates movement during ultrafast material transitions

UMBC scientists work to build “wind-up” sensors

Researchers receive McKnight award to study the evolution of deadly brain cancer

Heather Dyer selected as the 2024 ESA Regional Policy Award Winner

New study disputes Hunga Tonga volcano’s role in 2023-24 global warm-up

Climate is most important factor in where mammals choose to live, study finds

New study highlights global disparities in activity limitations and assistive device use

Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD

Meet Insilico in Singapore: Alex Zhavoronkov PhD shares insights into various aspects of AI-powered drug discovery

Insilico Medicine introduces Science42: DORA, the intelligent writing assistant for accelerated research

A deep dive into polyimides for high-frequency wireless telecommunications

Green hydrogen from direct seawater electrolysis- experts warn against hype

Thousands of birds and fish threatened by mining for clean energy transition

Medical and educational indebtedness among health care workers

US state restrictions and excess COVID-19 pandemic deaths

Posttraumatic stress disorder among adults in communities with mass violence incidents

New understanding of fly behavior has potential application in robotics, public safety

[Press-News.org] SRI relaunches the PARC Forum event series as it celebrates the first anniversary of acquiring the storied Palo Alto Research Center